Diagnosing and Treating COVID-19
Testing: We have both PCR nasal swab (for travel), and the rapid Antigen test both with similar accuracy.
Vaccinations: We offer Moderna vaccinations.
Testing After Infection or Vaccination is not necessary for healthy individuals. See Dr Marty Makary’s WSJ Editorial. Immunity from prior infection or vaccination provides rapid antibody response preventing serious illnesses. Details: SARS-COV-2 T Cell Immune Response
We can test for COVID19 antibodies to detect prior infection infection.
Treatment: We have several treatment options: we may use Budesonide, Dexamethasone, Hydroxychloroquine, Azithromycin, and Ivermectin with Zinc, Vit C&D to treat positive cases of COVID 19, depending on each individual’s illness. If respiratory symptoms worsen, we can also coordinate to use home oxygen.
Early Out-Patient SARS-CoV-2 Treatment Protocols.
Dr McCullough’s Texas Senate Testimony.
Long-Haulers and Complications: COVID19 can cause a variety of longer term complications, and we evaluate each person carefully to customize treatment to return to normal.
Vaccine Controversies: There is a lot of misinformation. ZDoggMD.com has several excellent videos or Vaccine Details from CHOP. In healthcare, the benefits obviously outweigh remote risks. There are rare side effects, but they do not cause sterilization, spread of spike proteins, or allow tracking (cell phones do that already.) There are many discredited theories, antibody dependent enhancement or spike protein shedding, that use a little science to intentionally cause confusion and put people at risk. There are no surges of COVID in vaccinated populations; COVID cases have dropped dramatically. Also, Ivermectin has shown some benefit in small trials but has not been studied for long term use and is not a substitute for vaccinations.
Ivermectin is not a substitute for vaccines. FLCCC encourages vaccinations and ivermectin only as a bridge. We do not know the long term effects of ivermectin for long periods at higher doses with rare reports of neurologic side effects.
Research starting with SARS in 2002-3 has shown Chloroquine and Hydroxychloroquine block COVID19 from getting into our cells and further hinders viral replication (multiplying). Azithromycin (Z-pack) also has a biochemical effect of hindering viral replication and activating various molecules in our immune system to fight viral infections. Hydroxychloroquine is one of the drugs that helps Zinc get into the cell. The three work together by hindering COVID19 virus.
This link provides a summary of current understanding of COVID19 – Features, Evaluation and Treatment of COVID19
Bradykinin hypothesis – The virus attaches onto a receptor called ACE2 to get into our cells then hijack our proteins to reproduce itself. ACE2 helps control our blood pressure and we have more as we age, which is why children are rarely ill. Link below explains in more details the symptoms caused by dysregulation of ACE2 and Bradykinin secreting hyaluronic acid in lungs.
What makes COVID-19 so hard to kill?
Unlike antibiotics that actually kill bacteria, only an individual’s white blood cells can kill the virus (Antibodies are critical component, called IgM and IgG). We treat COVID19 using medications to hinder viral growth and respiratory support until the body can get ahead of and then clear the viral load. All therapies are designed to hinder viral growth and help us survive long enough to clear the virus. This is challenging for older patients, poor immunity (HIV, chemotherapy, etc.), or lung disease. Simple soap destroys the viral capsules outside the body and is why we wash everything.
Similarly to Tamiflu or Xofluza for influenza, the earlier we treat the better.
Checkout the Research
A fundamental principle of medical research ethics is to stop a trial early if there is harm to patients and not withhold treatment if there is benefit. The term in the press “unproven” is misleading. Nothing is “proven” in medicine, only the amount of evidence that supports or opposes a therapy. The principle of do no harm to an individual is more important than any specific research methodology.
- Early Out-Patient SARS-CoV-2 Treatment Protocols. December 2020
- I-MASK, Early Ivermectin + Protocols, January 2021
- Global trends in clinical studies of ivermectin in COVID-19. March 2021
- C19Study.com provides a catalog of studies showing benefits of early treatment. Excellent current summary of research.
- Chloroquine as inhibitor of SARS, 2005
- Azithromycin induces anti-viral responses 2010
- Remdesivir and chloroquine inhibit in vitro, Jan 28, 2020
- Hydroxychloroquine and Azithromycin Early Treatment, Marseilles France, May 5, 2020
- Bradykinin Hypothesis – Disregulation of ACE2 and Bradykinin explains most COVID19 symptoms.
- Hydroxychloroquine, Zinc and Azithromycin Early Out-Patient Treatment. December 2020
- Features, Evaluation and Treatment of COVID19 August 2020